Sun Pharma's latest acquisition of Organon is worth 12 billion, which raises the Mergers and Acquisitions activity in India for the next four years
Glenmark has expanded its presence in the US pharmaceutical market with the launch of its Fast-Acting Schizophrenia Injection, a generic version of Olanzapine for Injection, 10 mg/vial.
The Hyderabad Pharma Firm, Shantha Biologics, has secured a major manufacturing agreement with Novo Nordisk, marking another milestone for India's pharmaceutical sector.
EMA has recently approved Lupin's drug capsules that could change the care for the rare muscle disorder, non-dystrophic myotonias that is seen in one among a million people
New hormone plant has become the latest milestone for Corona Remedies as the company strengthens its position in women's healthcare with the commercial launch of a dedicated hormone manufacturing facility in Bhayla, Ahmedabad.
India's Pharma Exports are entering a new phase as drugmakers expand beyond their biggest market, the US, to tap fresh opportunities in Brazil.
Haryana has initiated a project under the Pharmaceuticals and Medical Devices Manufacturing Policy 2026, which attracts 10,000 crore in investment and 20,000 job opportunities, thereby making Haryana a unique state in coming up with likely projects
Medical Device Licences could soon become easier and quicker to obtain in India, a move that may do more than reduce paperwork.
Lupin secures a tentative approval from the USFDA further expanding India as the global leader in the pharmaceutical industry the drug actively blocks testosterone from stimulating cancer cell growth
Alembic Pharma has gained entry into the USD 27 million US flu drug market after receiving USFDA approval for its generic flu drug, Oseltamivir Phosphate for Oral Suspension.
.jpg)
, CDSCO.jpg)